Highlight

CLINICAL RESEARCH 2004, June 24   The Poitiers hospital (CHU) stakes its claim   The clincial investigations entrusted to the CHU should be growing appreciably in the months to come.   The emergence of the clinical research center directed by Professor François Guilhot presently enables the CHU to bolster its claim to fame in various disciplines, among which oncology-hematology, diabetes and clinical epidemiology may fairly be said to have star billing. Just like other establishments, the Poitiers CHU is doing all it can to develop clinical research within its premises. In fact, this is one of the prime objectives of the general manager, Jean-Pierre Dewitte. In a move essential to its upcoming growth, the clinical research center (CRC) set up in March 1992 underwent thoroughgoing restructuring late last year. The person entrusted with the coordination was Pr. François Guilhot, general delegate in clinical research and eminent head of the Poitiers hospital's hematology-oncology laboratory. François Guilhot intends to make his international renown redound to the benefit of the CHU. Author of widely recognized research works on chronic myeloid leukemia, the interested party is no newcomer to publication. "My team and I have been working on this theme since 1984, so he insists. In 1997, I had a first paper appear in the New England Journal of Medicine. I also published an article on this disease in December 2003 in Blood, a major impact factor." In the watchful eyes of the INSERM, these publications furnish multiple proof of high seriousness. Obtaining a quality label The objective? To obtain as soon as possibke the INSERM label and thereby transform the CRC into a Center of Clinical Investigation. "The CHU has submitted to the Institute this type of request", indicates Sarah Guyon, the administrative manager. Awaiting this precious label, the Clinical Resarch delegation of the Poitou-Charentes region has expressed the wish to reorient the CRC in three guiding directions: onco-hematology with Professors Guilhot, Tourani (medical oncology department head), Daban (oncology radiotherapy), Bataille (neurosurgery) and Kraimps (visceral surgery); diabetes and its renal complications, with Dr. Hadjaj; as well as clinical epidemiology and the prevention of cardiovascular diseases, with Pr. Herpin (cardiologist). On the fringes of the CRC, other research activities have likewise been cropping up in the clinical departments. One example is dermatology, in which Pr. Guilhot has been conducting numerous investigations on behalf of private promoters, notably in "dealing with cases of psoriasis and chronic urticaria", states Sarah Guyon. In the anesthesia and intensive care areas, Pr. Debaene and his team are also studying antibiotic resistance in nosocomial infections… http://www.chu-poitiers.fr The Biopole en masse at Eurobio 2008 Read ...   Water information days (September 23 – September 25) Read ...   The rose and its genetic transformation Read ...   Christian Huyghe aims for “excellence” read...   Creating “medical branches” read...   A neuro-cardio-vascular pole is taking root read...   Valagro on the horticulture market read...   ERM, the winning spin-off read...   GMOs under debate in Poitiers read...   Isabelle Cameleyre, new representative read...   Cystic fibrosis: The molecule of hope read...   Irfaq, a manufacturer of innovations read...   CHU: State-of-the-art quality read...   Soil organic matter under examination read...   Parexel: The Cap provides its support read...   Philippe Michonneau: “The Biopole, fertile soil” read...   Painless monitoring of hepatitis read...   The Biopole structured as an association read...   Futuramat steps up the pace read...   Technova, or life in 3D read...   B Braun burnishes its image read...   Proteomics platform: The CHU strides ahead read...   The three missions of the University Botanical Garden read...   Clinsight in the big leagues read...   Natural energies for an autonomous building read...   Aster-Cephac turns into SGS Cephac read...   The previously unseen heart read...   BIOalternatives diversifies its markets read...   Two Poitiers-based projects awarded read...   IUT pores over biofuels read...   Poitiers, the biotechnology capital read...   PAREXEL wagers on the human factor read...   Saunier and associates wish to diversify read...   Biocydex and BioXtract move forward hand in hand read...   The grass of champions read...   Ianesco steadfastly believes in its future read...   A tumorotheque, what is the purpose it serves? read...   TechnAvOx has turned the corner read...   Larime is aiming for 40 beds in Poitiers read...   Poitiers is out to promote its research read...   A true Biopole milestone read...   A regional cancerology pole in the pipeline for 2007 read...   Nobel prize winners in Poitiers read...   A platform offering numerous advantages read...   @rtMolecule fashions in its own way read...   It’s plastic, it’s fantastic read...   The Poitiers hospital (CHU) stakes its claim read...   BIOalternatives exports its know-how read...   The physiological and computer science engineering program turns 30 read...   The Biopole takes center stage at Investiga read...           Legal mentions